Biomarkers of Exposure, Effect, and Susceptibility

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Epidemiological research fundamentally involves the identification of relationships between previous exposures to putative causative agents and subsequent adverse biological effects in study populations. Molecular epidemiology encompasses the use of biomarkers in epidemiological research through the incorporation of molecular, cellular, organ system, and other biochemical and physiological measurements into studies of association, etiology, prevention, and control of health risks encountered by human populations. Application of validated biomarkers to traditional epidemiological studies helps to delineate the continuum of events between an exposure and resulting disease; to identify smaller exposures to specific xenobiotics; to indicate earlier events in the natural history of diseases and reduce misclassification of dependent and independent variables; to enhance individual and group risk monitoring and assessments; and to reveal toxicologic mechanisms by which an exposure and a disease are related. This field of research has been most extensively explored in cancer, but in recent years the use of molecular biomarkers reflecting the progression pathways in cardiovascular disease and neurological disorders has been rapidly increasing. Thus, methods to more accurately and sensitively characterize exposure, effects, and susceptibility are needed in research involving environmental agents. Collectively, these data also help to inform the risk assessment process, where regulations can be tested against biological measurements of exposure to determine the efficacy of the regulations, and most recently these tools have been applied to the problems of assessing cumulative risk.

Original languageEnglish (US)
Title of host publicationComprehensive Toxicology
Subtitle of host publicationSecond Edition
PublisherElsevier Inc.
Pages225-243
Number of pages19
Volume1-14
ISBN (Print)9780080468846
DOIs
StatePublished - Jan 1 2010

Fingerprint

Biomarkers
Research
Molecular Epidemiology
Xenobiotics
Nervous System Diseases
Population
Epidemiologic Studies
Cardiovascular Diseases
Health
Neoplasms

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Links, J. M., & Groopman, J. D. (2010). Biomarkers of Exposure, Effect, and Susceptibility. In Comprehensive Toxicology: Second Edition (Vol. 1-14, pp. 225-243). Elsevier Inc.. https://doi.org/10.1016/B978-0-08-046884-6.00111-1

Biomarkers of Exposure, Effect, and Susceptibility. / Links, J. M.; Groopman, J. D.

Comprehensive Toxicology: Second Edition. Vol. 1-14 Elsevier Inc., 2010. p. 225-243.

Research output: Chapter in Book/Report/Conference proceedingChapter

Links, JM & Groopman, JD 2010, Biomarkers of Exposure, Effect, and Susceptibility. in Comprehensive Toxicology: Second Edition. vol. 1-14, Elsevier Inc., pp. 225-243. https://doi.org/10.1016/B978-0-08-046884-6.00111-1
Links JM, Groopman JD. Biomarkers of Exposure, Effect, and Susceptibility. In Comprehensive Toxicology: Second Edition. Vol. 1-14. Elsevier Inc. 2010. p. 225-243 https://doi.org/10.1016/B978-0-08-046884-6.00111-1
Links, J. M. ; Groopman, J. D. / Biomarkers of Exposure, Effect, and Susceptibility. Comprehensive Toxicology: Second Edition. Vol. 1-14 Elsevier Inc., 2010. pp. 225-243
@inbook{acf2d1496ab14bb58fc5b0bb3f918ca9,
title = "Biomarkers of Exposure, Effect, and Susceptibility",
abstract = "Epidemiological research fundamentally involves the identification of relationships between previous exposures to putative causative agents and subsequent adverse biological effects in study populations. Molecular epidemiology encompasses the use of biomarkers in epidemiological research through the incorporation of molecular, cellular, organ system, and other biochemical and physiological measurements into studies of association, etiology, prevention, and control of health risks encountered by human populations. Application of validated biomarkers to traditional epidemiological studies helps to delineate the continuum of events between an exposure and resulting disease; to identify smaller exposures to specific xenobiotics; to indicate earlier events in the natural history of diseases and reduce misclassification of dependent and independent variables; to enhance individual and group risk monitoring and assessments; and to reveal toxicologic mechanisms by which an exposure and a disease are related. This field of research has been most extensively explored in cancer, but in recent years the use of molecular biomarkers reflecting the progression pathways in cardiovascular disease and neurological disorders has been rapidly increasing. Thus, methods to more accurately and sensitively characterize exposure, effects, and susceptibility are needed in research involving environmental agents. Collectively, these data also help to inform the risk assessment process, where regulations can be tested against biological measurements of exposure to determine the efficacy of the regulations, and most recently these tools have been applied to the problems of assessing cumulative risk.",
author = "Links, {J. M.} and Groopman, {J. D.}",
year = "2010",
month = "1",
day = "1",
doi = "10.1016/B978-0-08-046884-6.00111-1",
language = "English (US)",
isbn = "9780080468846",
volume = "1-14",
pages = "225--243",
booktitle = "Comprehensive Toxicology",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Biomarkers of Exposure, Effect, and Susceptibility

AU - Links, J. M.

AU - Groopman, J. D.

PY - 2010/1/1

Y1 - 2010/1/1

N2 - Epidemiological research fundamentally involves the identification of relationships between previous exposures to putative causative agents and subsequent adverse biological effects in study populations. Molecular epidemiology encompasses the use of biomarkers in epidemiological research through the incorporation of molecular, cellular, organ system, and other biochemical and physiological measurements into studies of association, etiology, prevention, and control of health risks encountered by human populations. Application of validated biomarkers to traditional epidemiological studies helps to delineate the continuum of events between an exposure and resulting disease; to identify smaller exposures to specific xenobiotics; to indicate earlier events in the natural history of diseases and reduce misclassification of dependent and independent variables; to enhance individual and group risk monitoring and assessments; and to reveal toxicologic mechanisms by which an exposure and a disease are related. This field of research has been most extensively explored in cancer, but in recent years the use of molecular biomarkers reflecting the progression pathways in cardiovascular disease and neurological disorders has been rapidly increasing. Thus, methods to more accurately and sensitively characterize exposure, effects, and susceptibility are needed in research involving environmental agents. Collectively, these data also help to inform the risk assessment process, where regulations can be tested against biological measurements of exposure to determine the efficacy of the regulations, and most recently these tools have been applied to the problems of assessing cumulative risk.

AB - Epidemiological research fundamentally involves the identification of relationships between previous exposures to putative causative agents and subsequent adverse biological effects in study populations. Molecular epidemiology encompasses the use of biomarkers in epidemiological research through the incorporation of molecular, cellular, organ system, and other biochemical and physiological measurements into studies of association, etiology, prevention, and control of health risks encountered by human populations. Application of validated biomarkers to traditional epidemiological studies helps to delineate the continuum of events between an exposure and resulting disease; to identify smaller exposures to specific xenobiotics; to indicate earlier events in the natural history of diseases and reduce misclassification of dependent and independent variables; to enhance individual and group risk monitoring and assessments; and to reveal toxicologic mechanisms by which an exposure and a disease are related. This field of research has been most extensively explored in cancer, but in recent years the use of molecular biomarkers reflecting the progression pathways in cardiovascular disease and neurological disorders has been rapidly increasing. Thus, methods to more accurately and sensitively characterize exposure, effects, and susceptibility are needed in research involving environmental agents. Collectively, these data also help to inform the risk assessment process, where regulations can be tested against biological measurements of exposure to determine the efficacy of the regulations, and most recently these tools have been applied to the problems of assessing cumulative risk.

UR - http://www.scopus.com/inward/record.url?scp=84902222350&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84902222350&partnerID=8YFLogxK

U2 - 10.1016/B978-0-08-046884-6.00111-1

DO - 10.1016/B978-0-08-046884-6.00111-1

M3 - Chapter

AN - SCOPUS:84902222350

SN - 9780080468846

VL - 1-14

SP - 225

EP - 243

BT - Comprehensive Toxicology

PB - Elsevier Inc.

ER -